MAIA (MAIA) director boosts stake with 57,189-share buy and new options
Rhea-AI Filing Summary
MAIA Biotechnology director Stan V. Smith reported buying additional shares and options in the company. On December 22, 2025, he purchased 57,189 shares of MAIA common stock at $1.224 per share under a Securities Purchase Agreement and the company’s 2021 Equity Incentive Plan. After this transaction, he beneficially owns 1,421,478 shares indirectly through The Stan V. Smith Trust Dated 1993, plus additional indirect holdings of 4,580 shares in each of three separate family trusts.
He also acquired 57,189 stock options (described as warrants deemed options) with an exercise price of $1.36 per share. These options become exercisable on the six-month anniversary of the issuance date, June 22, 2026, and expire three years after the initial issuance date, on December 22, 2028. The filing notes that certain family-trust shares are held for relatives and that he disclaims beneficial ownership of those except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Stock Options | 57,189 | $1.36 | $78K |
| Purchase | Common Stock | 57,189 | $1.224 | $70K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993. These securities are beneficially owned by Mr. Smith through the Blake Sarai Teitei Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. These securities are beneficially owned by Mr. Smith through the Gage Quentin Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. These securities are beneficially owned by Mr. Smith through the Travis Deo Zai Zai Smith IL Unif Trns Min Act. They are beneficially owned by Mr. Smith's family member. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on December 22, 2025. The options are exercisable beginning on the sixth month anniversary of the issuance date and expire 3-years after the initial issuance date. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
FAQ
What insider transaction did MAIA (MAIA) disclose for December 22, 2025?
MAIA disclosed that director Stan V. Smith purchased 57,189 shares of common stock on December 22, 2025 at a price of $1.224 per share under a Securities Purchase Agreement and the company’s 2021 Equity Incentive Plan.
What options or warrants did Stan V. Smith acquire in MAIA (MAIA)?
He acquired 57,189 stock options (warrants deemed options) with an exercise price of $1.36 per share. These are linked to an equal number of underlying MAIA common shares.
When can Stan V. Smith’s MAIA options be exercised and when do they expire?
The 57,189 options become exercisable on June 22, 2026, the six-month anniversary of the issuance date, and they expire on December 22, 2028, three years after the initial issuance date.